Successful Treatment of Lupus Anticoagulant-Hypoprothrombinemia Syndrome Using Intravenous Immunoglobulins

Gilles Pernod; Josiane Arvieux; Patrick H Carpentier; Pascal Mossuz; Jean Luc Bosson; Benoît Polack

doi:10.1055/s-0038-1657668

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1997; 78(02): 969-970
DOI: 10.1055/s-0038-1657668

Letter to the Editor

Schattauer GmbH Stuttgart

Successful Treatment of Lupus Anticoagulant-Hypoprothrombinemia Syndrome Using Intravenous Immunoglobulins

Gilles Pernod

¹The Laboratoire d’Hématologie, Centre de Transfusion Sanguine, Grenoble, France

,

Josiane Arvieux

²Laboratoire d’Immunologie, Centre de Transfusion Sanguine, Grenoble, France

,

Patrick H Carpentier

³Service de Médecine Interne- Angiologie, CHU de Grenoble, Centre de Transfusion Sanguine, Grenoble, France

,

Pascal Mossuz

¹The Laboratoire d’Hématologie, Centre de Transfusion Sanguine, Grenoble, France

,

Jean Luc Bosson

³Service de Médecine Interne- Angiologie, CHU de Grenoble, Centre de Transfusion Sanguine, Grenoble, France

,

Benoît Polack

¹The Laboratoire d’Hématologie, Centre de Transfusion Sanguine, Grenoble, France

› Author Affiliations

Abstract

PDF Download

PDF (444 kb)

References

References
1 Arvieux J, Damige L, Caron C, Reber G, Bensa JC, Colomb MG. Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants. Thromb Haemost 1995; 74: 1120-1125
2 Fleck RA, Rapaport SI, Rao VM. Anti-prothrombin antibodies and the lupus anticoagulant. Blood 1988; 72: 512-519
3 Edson JR, Vogt JM, Hasegawa DK. Abnormal prothrombin crossed-immu- noelectrophoresis in patients with lupus inhibitors. Blood 1984; 64: 807-816
4 Bajaj SP, Rapaport SI, Fierer DS, Herbst KD, Schwartz DB. A mechanism for the hypoprothrombinemia of the acquired hypoprothrombinemia-lupus anticoagulant syndrome. Blood 1983; 61: 684-692
5 Peacock NW, Levine SP. The lupus anticoagulant-hypoprothrombinemia syndrome. Am J Med Sciences 1994; 307: 346-349
6 Bernini JC, Bushanan GR, Ashcraft J. Hypoprothrombinemia and severe hemorrhage associated with a lupus anticoagulant. J Pediatr 1993; 123: 937-939
7 Lee MT, Nardi MA, Hu G, Hadzi-Nesic J, Karpatkin M. Transient hemorrhagic diathesis associated with an inhibitor of prothrombin with lupus anticoagulant in a 1 1/2-year-old girl: report of a case and review of the literature. Am J Hematol 1996; 51: 307-314
8 Simel DL, St ClairEW, Adams J, Greenberg CS. Correction of hypoprothrombinemia by immunosuppressive treatment of the lupus antico- agulant-hypoprothrombinemia syndrome. Am J Med 1987; 83: 563-566
9 Mouthon L, Hurez V, Kazatchkine M. Mechanisms of action of intravenous immunoglobulins (IglV) in the treatment of autoimmune diseases. An Med Interne 1993; 144: 506-513
10 Carreras LO, Perez GN, Martinuzzo ME, Malan-Borel I, Malbran A, Said PB. Partial neutralization of a lupus anticoagulant by human immunoglobulin. Thromb Haemost 1990; 64: 32-37
11 Galli M, Cortelazzo S, Barbui T. In vivo efficacy of intravenous immunoglobulins in patients with lupus anticoagulant is not mediated by an anti- idiotypic mechanism. Am J Hematol 1991; 38: 184-188
12 Hanley D, Arkel YS, Lynch J, Kamiyama M. Acquired von Willebrand’s syndrome in association with a lupus-like anticoagulant corrected by intravenous immunoglobulin. Am J Hematol 1994; 46: 141-146
13 Reznikoff-Etievant M, De LachauxY, Marpeau L, Courouce AM. Intravenous immunoglobulin and hepatitis C transmission in healthy pregnant women. Lancet 1992; 340: 986